[Phase II trial with cisplatin in ovarian malignancies]
Nihon Gan Chiryo Gakkai Shi
.
1982 Feb 20;17(1):31-40.
[Article in Japanese]
Authors
T Hosokawa
,
H Ito
,
T Tanaka
,
K Ichinoe
,
Y Yamada
,
M Suzuki
,
A Yajima
,
T Mori
,
H Takamizawa
,
S Sekiya
,
S Sakamoto
,
T Kawana
,
J T Chen
,
M Takada
,
H Takeuchi
,
K Akiya
,
S Hara
,
Y Hara
,
S Takeuchi
,
K Kanazawa
,
H Yoshizawa
,
Y Tomoda
,
M Ohta
,
S Hattori
,
Y Yagami
,
K Mizuno
,
K Koike
,
Y Suzuoki
,
R Totani
,
T Miwa
,
O Sugimoto
,
A Fujimoto
,
S Doi
,
S Tojo
,
M Iwasaki
,
K Sekiba
,
I Kohno
,
H Okazaki
,
S Ogawa
,
M Seto
,
Y Komoto
,
I Taki
,
N Tsukamoto
,
T Iwasaka
,
T Yamabe
,
H Nakajima
,
M Yoshida
PMID:
6890088
No abstract available
Publication types
English Abstract
MeSH terms
Adult
Aged
Cisplatin / administration & dosage
Cisplatin / adverse effects
Cisplatin / therapeutic use*
Drug Administration Schedule
Drug Evaluation
Female
Humans
Middle Aged
Ovarian Neoplasms / drug therapy*
Substances
Cisplatin